Beating Diabetes, One Capsule at a Time:
How Sugar Cut Is Making Spikes Vanish and Health Reboot
Problem: India’s Silent Sugar Crisis Grows
India is the diabetes capital of the world, but most patients are left guessing. Even “healthy” Indian meals cause sharp blood sugar spikes. Insulin resistance builds over time, making traditional meds less effective. Meanwhile, silent killers like AGEs (Advanced Glycation End-products) damage organs. Sugar Cut steps in with smart, science-backed products to restore control and stop the damage at its root.
Most diabetics rely on home remedies or misinformation.
Post-meal sugar spikes cause fatigue, fog, and long-term harm.
Insulin resistance worsens silently, even with meds.
AGEs damage organs, yet most Indians don’t know they exist.
Earning Model: Multi-Channel, Subscription-Ready Revenue
D2C through website, Amazon & Flipkart.
B2B sales to pharmacies and diabetic clinics.
Tech-enabled subscription for insights & supplements.
Upsell bundles based on AI-driven glucose response.
Sugar Cut earns by being exactly where its users are—online, offline, and in clinics. Starting with D2C sales via e-commerce, they’re expanding to pharmacies and hospitals. The real magic? AI-driven subscription plans that personalize supplement bundles using CGM data. It’s smart, recurring, and scales naturally as results kick in.
Risk: Education, Adoption, and Market Noise
Market flooded with generic or Ayurvedic products.
Consumer trust must be earned via clear science.
Subscription model adoption depends on CGM integration.
Needs to scale tech without alienating older consumers.
This isn’t just a product—it’s a category reset. But resetting habits requires patient education. Sugar Cut has to break through the noise of Ayurvedic gimmicks and win trust with real clinical results. The team is tackling this head-on with influencer education, CGM case studies, and results-driven storytelling.
Founder’s Story: From Performance Marketing to Personal Mission
Shanaya Fernandes led campaigns for 40+ brands, including HDFC Life & Food Darzee.
Omkar Gujran is a national-level athlete with ops and sales experience.
Built and scaled a healthcare marketing agency featured in Entrepreneur India.
Together, they saw a data gap in India’s diabetes fight—and moved fast to fix it.
Shanaya wasn’t just selling supplements—she was watching the industry from the inside. After working with major healthcare clients, she realized no one was truly solving the sugar crisis. Partnering with Omkar, a performance-first operator with deep health roots, they built Sugar Cut: a brand that uses science, tracking, and trust to give diabetics a real shot at freedom.
Entry Barriers: Deep Science, Personalization & Trust
- First in India to target AGEs with clinically backed formulas.
- Proprietary CGM + AI feedback loop in development.
- Precision-focused—no generic blends, no vague promises.
- Transparent formulation, clear results, repeat use.
Anyone can make capsules. But not everyone builds clinical-grade formulas for insulin resistance and AGEs. Sugar Cut’s science-first approach, layered with CGM data, makes it hard to replicate. It’s not about herbs—it’s about measurable change. And that’s hard to copy.
Competition & Comparables: Why Others Fall Short
- Wellbeing Nutrition: High-quality, but pricey and lacks personalization.
- Organic India & BGR-34: Ayurvedic, but unverified by science.
- Ensure Diabetes Care: Nutritional but not targeted at insulin/AGEs.
- Sugar Cut = affordable + focused + tech-integrated.
Competitors rely on either high cost, vague herbal claims, or one-size-fits-all nutrition. Sugar Cut stands alone: science-backed, results-driven, and on the path to real-time personalization. While others give you a generic capsule, Sugar Cut learns how you respond—and evolves with you.
Team: Healthcare Hustlers with Proven Execution
Shanaya: Founder of a marketing agency with 40+ health brands.
Omkar: Sales & ops veteran who scaled teams and clients.
Advisory network includes clinicians and biohackers.
Built and launched product + distribution channels within months.
This isn’t a team experimenting from scratch. They know how to scale fast, sell smart, and speak to their audience. From launching products to building offline B2B channels, the team has moved from zero to traction in record time—with domain expertise and drive.
Size of Market: A $21 Billion Indian Opportunity
India’s diabetes care market: $15B (2024), $21.56B by 2030.
Global diabetes market: $50.3B by 2030.
CAGR: 6.18% India, 7.45% Global.
Rising demand for natural + tech-powered solutions.
The numbers are staggering. Over 100 million Indians have diabetes—and the market’s only growing. As people shift to natural yet effective interventions, Sugar Cut sits at the perfect intersection: clinically backed and tech-enabled. The addressable market is massive, and Sugar Cut is ready to lead.
Ask: Fuel the Next Phase of Precision Health
Capital to build mobile app & AI-based CGM dashboard.
Funds for influencer-led awareness campaigns.
Inventory and retail expansion across Tier 2–3 India.
Team growth to support ops, R&D, and offline distribution.
The foundation is set. The brand, the product, the demand—it’s all in place. What Sugar Cut needs now is fuel: to finish the tech loop, expand into clinics and pharmacies, and tell its story at scale. Investors aren’t just backing a product—they’re backing a future where India reclaims its sweet life.
Innovation: A Feedback Loop That Heals
AI-powered CGM insights + supplement feedback.
First to target AGEs in Indian market.
Dynamic product bundling based on user data.
Science-based lifestyle guidance—not just pills.
Sugar Cut doesn’t just sell pills—it builds intelligence. Imagine a user eating lunch, seeing their spike, and instantly knowing what supplement to take and how to adjust their habits. This is where tech meets biology. It’s not just health—it’s healing, personalized.
Niche: India’s Health-Conscious & Diabetic Populations
Type 2 diabetics needing daily sugar control.
Pre-diabetics & high-risk individuals wanting to prevent disease.
Health-conscious biohackers focused on metabolic health.
Middle-income India ready to shift from meds to smart wellness.
Sugar Cut isn’t just for diabetics—it’s for the 200 million people on the edge. It serves biohackers who want control, families with a history of sugar issues, and people tired of side effects. This is a brand for people who don’t want to manage diabetes—they want to fight it.
Traction: Built with Speed and Proof
Launched and operational in D2C channels.
Built pharmacy partnerships and clinical network.
Influencer seeding + education campaigns underway.
Strong user feedback and early adoption in Tier 1–2 cities.
Sugar Cut went from idea to shelf in months. They’ve launched on Amazon, built pharmacy distribution, and engaged influencers in the wellness space. Customers are seeing real results—and asking for more. With a base now built, the next phase is scale.
Scalability: Designed for National and Global Expansion
Mobile app + CGM tech in development.
Product line expansion underway (insulin boosters, AGEs blockers).
Strong potential in Middle East & Southeast Asia.
Subscription model ensures long-term retention and growth.
Everything Sugar Cut is building—from tech to operations—is made to scale. The plan is already in motion: app features, new products, and expansion across regions with similar problems. Recurring revenue via personalized subscriptions means this isn’t a one-time fix—it’s a long-term wellness platform.